Reasons for Enrolling in Safer Supply Programs: A Longitudinal Qualitative Study on Participant Goals and Related Outcomes in the MySafe Program
Journal of Studies on Alcohol and Drugs · 2024-11 · 85 (6) · 845-855
DOI: 10.15288/jsad.23-00388 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift Journal of Studies on Alcohol and Drugs, 2024-11. Verfasst von Andrew Ivsins und 3 weiteren Autor:innen. Beteiligte Einrichtung: British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Goals, Harm Reduction. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.
- Department of Medicine, University of British Columbia, St. Paul's Hospital, Vancouver, British Columbia, Canada.
- School of Public Health Sciences, Faculty of Health, University of Waterloo, Waterloo, Ontario, Canada.
Zitieren
APA
Ivsins, A., Mansoor, M., Bowles, J., & Bardwell, G. (2024). Reasons for Enrolling in Safer Supply Programs: A Longitudinal Qualitative Study on Participant Goals and Related Outcomes in the MySafe Program. Journal of Studies on Alcohol and Drugs, 85(6), 845-855. https://doi.org/10.15288/jsad.23-00388
Vancouver
Ivsins A, Mansoor M, Bowles J, Bardwell G. Reasons for Enrolling in Safer Supply Programs: A Longitudinal Qualitative Study on Participant Goals and Related Outcomes in the MySafe Program. Journal of Studies on Alcohol and Drugs. 2024;85(6):845-855. doi:10.15288/jsad.23-00388
BibTeX
@article{Ivsins2024,
author = {Ivsins, Andrew and Mansoor, Manal and Bowles, Jeanette and Bardwell, Geoff},
title = {Reasons for Enrolling in Safer Supply Programs: A Longitudinal Qualitative Study on Participant Goals and Related Outcomes in the MySafe Program},
journal = {Journal of Studies on Alcohol and Drugs},
year = {2024},
volume = {85},
number = {6},
pages = {845--855},
doi = {10.15288/jsad.23-00388}
}
EUVIMED